correlation between precore/basal core promoter varaints and HBV genotypes, serum HBV DNA levels and liver disease

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OCS-11001739

Enrollment

Unknown

Registered

2011-11-30

Start date

2009-03-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic hepatitis B

Interventions

Case series:Nil

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Diagnose of Chronic hepatitis B; Not receiving antiviral treatment recently

Exclusion criteria

Exclusion criteria: Presence of serum antibodies against hepatitis C virus (HCV), or humanimmunodeficiency virus (HIV); other acquired or inherited liver disease; receiving antiviral currently, coexisting serious disease; advanced liver disease (including decompensated cirrhosis, severe hepatitis, hepatocellular carcinoma).

Design outcomes

Primary

Measure	Time frame
HBV Genotype;HBV precore/basal core promoter mutation;HBeAg;	—

Secondary

Measure	Time frame
HBsAg;	—

Countries

China

Contacts

Public ContactHong Tang

htang6198@hotmail.com+86 18980601313

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026